ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 735331 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 735331; 2) Community: the network communities that were significantly associated with the response to NSC 735331; 3) Molecule: the relationships between components within communities and NSC 735331; 4) MDR: the compounds that were significantly associated with the NSC 735331.

NSC Compound Enrichment Correlation
NSC 603974 Null 0.000497857311992526 0.42036237
NSC 674915 Null 0.000497857311992526 0.072263185
NSC 699757 Null 0.000497857311992526 0.40708126
NSC 705331 2-Propenamide, N-(1,1-dimethylethyl)-N-(phenylmethyl)- 3-(phenylsulfinyl)-, (2Z)- 0.000497857311992526 0.29773948
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.000659507126432943 0.18445601
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.000706163530262832 0.48385154
NSC 708046 Null 0.000706163530262832 0.55843187
NSC 708048 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- 0.000706163530262832 0.52970364
NSC 726146 Null 0.000706163530262832 0.41837582
NSC 727286 6-(bromomethyl)-1,4-anthracenedione. 0.000706163530262832 0.33011505
Total:72  Current:3    [First] [Prev] [Next] [Last]